Prostate brachytherapy is a radiotherapy technique for early stage prostate cancer that uses imaging guidance to place radioactive sources directly into the prostate gland. Transrectal ultrasound is used to facilitate a template-guided transperineal approach to the prostate and permits a highly conformal method of prostate radiotherapy with doses far higher than can be achieved with other radiation techniques. Maturing data has validated this technique as an acceptable treatment option with favourable and durable biochemical outcomes. The radiologist has a major role to play in the process: patient selection, guiding source delivery and follow-up after treatment all require close collaboration with colleagues in Radiation Oncology and Medical Physics. This review emphasises the specific contribution of imaging in the context of currently reported outcomes data.

Author

Brendan Carey and Sarah Swift

Contact Details

Corresponding address:
Brendan Carey, Radiology Department, Cookridge Hospital, Leeds, LS16 6QB, UK

Reference

ICIS Cancer Imaging Volume 7 Issue 1
DOI: 10.1102/1470-7330.2007.0003

Date Posted

28 February 2007

View the Full Text article

Print PDF

Size

918.80 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	3 seconds
ADSL 512Kb/s (Broadband):	14 seconds
64 Kb/s (ISDN):	1 minute 54 seconds
33.3 Kb/s (Typical Modem):	3 minutes 40 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 231 7773 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.